Loading…
Loading grant details…
| Funder | Biotechnology and Biological Sciences Research Council |
|---|---|
| Recipient Organization | University of Glasgow |
| Country | United Kingdom |
| Start Date | Sep 30, 2024 |
| End Date | Sep 30, 2028 |
| Duration | 1,461 days |
| Number of Grantees | 1 |
| Roles | Supervisor |
| Data Source | UKRI Gateway to Research |
| Grant ID | 2925176 |
Cycles of ubiquitination and deubiquitination, the addition and removal of a 76 amino acid polypeptide to lysine residues of target proteins, play a key cellular role in controlling the turnover, localisation and activity of many proteins, thereby modulating many cellular reactions. Two such ubiquitin-regulated reactions are DNA repair and replication, which together maintain
and transmit all genomes. Nothing is known about how ubiquitination acts during Leishmania DNA repair or replication, but this grouping of single-celled eukaryotic parasites displays remarkable genome plasticity, manifest as both changes in gene and chromosome copy number. This project will ask if and how ubiquitination regulates the DNA repair and replication
machineries of Leishmania, including how such modifications contribute to genome plasticity. In so doing, the project will provide new knowledge on the regulation of known genome maintenance machineries and will identify novel activities. In the long run, such knowledge provides the potential to develop improved and novel anti-Leishmania compounds targeting the
ubiquitination system. The project will involve training in cell culture and genetic manipulation, as well as in the generation and analysis of large-scale next generation DNA sequencing and proteomics datasets.
University of Glasgow
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant